Merck KGaA/Pfizer’s Bavencio fails in stomach cancer trialMerck KGaA and Pfizer’s cancer immunotherapy Bavencio has disappointed in a hard to treat late-stage gastric cancer trial, Share XMerck KGaA/Pfizer’s Bavencio fails in stomach cancer trialhttps://pharmaphorum.com/news/merck-kgaapfizers-bavencio-fails-stomach-cancer-trial/
